SQZ Biotechnologies (SQZ)
NYSE: SQZ
· Real-Time Price · USD
0.43
0.16 (59.26%)
At close: Jul 03, 2023, 7:00 PM
SQZ Biotechnologies Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -48M | -70.65M | -76.11M | -79.46M | -77.74M | -77.55M | -74.38M | -68.74M | -74.52M | -64.42M | -55.34M |
Depreciation & Amortization | 8.69M | 11.54M | 11.98M | 11.68M | 11.01M | 10.94M | 10.98M | 11.03M | 11.09M | 11.16M | 11.05M |
Stock-Based Compensation | 7.5M | 6M | 7.15M | 8.4M | 8.94M | 9.35M | 8.87M | 8.51M | 7.55M | 5.56M | 4.49M |
Other Working Capital | -25.24M | -31.36M | -34.18M | -27.25M | -25.48M | -23.65M | -23.74M | -26.33M | -16.01M | -15.95M | -16.31M |
Other Non-Cash Items | -4M | -115K | -8K | 33K | -32.9M | -32.9M | -32.89M | -32.93M | 11K | 25K | 36K |
Deferred Income Tax | n/a | n/a | n/a | n/a | 32.94M | 32.94M | 32.94M | 32.94M | n/a | n/a | n/a |
Change in Working Capital | -23.99M | -28.45M | -29.9M | -24.2M | -26.06M | -25.6M | -27.51M | -32.94M | -24.49M | -26.83M | -27.06M |
Operating Cash Flow | -55.92M | -81.68M | -86.89M | -83.55M | -83.81M | -82.82M | -81.99M | -82.14M | -80.36M | -74.5M | -66.83M |
Capital Expenditures | -213K | -326K | -359K | -522K | -421K | -400K | -594K | -613K | -736K | -910K | -1.1M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8M | 16M | 28M |
Other Investing Acitivies | 155K | 155K | n/a | 34K | 34K | 34K | 34K | n/a | n/a | n/a | n/a |
Investing Cash Flow | -58K | -171K | -359K | -488K | -387K | -366K | -560K | -613K | 7.26M | 15.09M | 26.9M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 29K | 29K | 29K | 29K | 103K | 103K | 103K | 103K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 331K | 1M | 4.2M | 4.23M | 4.18M | 3.68M | 532K | 55.91M | 130.29M | 129.84M | 156.71M |
Financial Cash Flow | 331K | 1M | 4.2M | 4.23M | 4.18M | 3.68M | 532K | 55.91M | 130.29M | 129.84M | 156.71M |
Net Cash Flow | -55.65M | -80.85M | -83.04M | -79.8M | -80.02M | -79.51M | -82.02M | -26.84M | 57.19M | 70.42M | 116.77M |
Free Cash Flow | -56.13M | -82.01M | -87.25M | -84.07M | -84.23M | -83.22M | -82.58M | -82.75M | -81.09M | -75.42M | -67.93M |